Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Longchai Formula (also referred to as Long Chai Fang or LCFG) is a traditional Chinese medicine (TCM) herbal formula developed by Professor Jin Shi of Nanjing University of Chinese Medicine. It is primarily used for the treatment of chronic hepatitis B. The formula has been evaluated in randomized controlled clinical trials and shown to improve symptoms associated with chronic hepatitis B, including liver function markers such as ALT and AST. The mechanism of action is not fully elucidated but is presumed to involve modulation of immune response and improvement in liver function based on TCM principles[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Longchai Formula.